The only at present permitted health care marijuana product is Sativex for multiple sclerosis similar spasticity. The region also voted down a press to remove CBD from the banned substances checklist in 2019. The survey final results showed that almost all of French citizens feel that cannabis need to be legalized for clinical needs and the